BCTX BriaCell Therapeutics Corp

Price (delayed)

$3.58

Market cap

$31.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.11

Enterprise value

$24.27M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 1

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

Highlights
The EPS has surged by 96% year-on-year and by 83% since the previous quarter
BriaCell Therapeutics's quick ratio has soared by 120% YoY but it has decreased by 32% from the previous quarter
The company's equity has surged by 96% YoY but it fell by 23% QoQ
The net income has shrunk by 58% YoY and by 3.4% QoQ

Key stats

What are the main financial stats of BCTX

BCTX stock price

How has the BriaCell Therapeutics stock price performed over time
Intraday
-3.76%
1 week
-4.02%
1 month
18.15%
1 year
-55.75%
YTD
-49.65%
QTD
10.49%

Financial performance

How have BriaCell Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32.03M
Net income
-$31.15M
Gross margin
N/A
Net margin
N/A
The net income has shrunk by 58% YoY and by 3.4% QoQ
The company's operating income fell by 31% YoY and by 4.2% QoQ

Price vs fundamentals

How does BCTX's price correlate with its fundamentals

Growth

What is BriaCell Therapeutics's growth rate over time

Valuation

What is BriaCell Therapeutics stock price valuation
P/E
N/A
P/B
1.11
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 96% year-on-year and by 83% since the previous quarter
The company's equity has surged by 96% YoY but it fell by 23% QoQ
The P/B is 11% more than the last 4 quarters average of 1.0

Efficiency

How efficient is BriaCell Therapeutics business performance
The return on equity has surged by 68% year-on-year and by 11% since the previous quarter
BriaCell Therapeutics's ROIC has soared by 52% from the previous quarter
BCTX's ROA is up by 29% year-on-year and by 8% since the previous quarter

Dividends

What is BCTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BCTX.

Financial health

How did BriaCell Therapeutics financials performed over time
BriaCell Therapeutics's quick ratio has soared by 120% YoY but it has decreased by 32% from the previous quarter
BriaCell Therapeutics's current ratio has surged by 107% YoY but it has decreased by 30% QoQ
The debt is 100% smaller than the equity
The company's equity has surged by 96% YoY but it fell by 23% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.